214 related articles for article (PubMed ID: 18007662)
1. From regulation of dying cell engulfment to development of anti-cancer therapy.
Krysko DV; Vandenabeele P
Cell Death Differ; 2008 Jan; 15(1):29-38. PubMed ID: 18007662
[TBL] [Abstract][Full Text] [Related]
2. Clearance of Dying Cells by Phagocytes: Mechanisms and Implications for Disease Pathogenesis.
Fond AM; Ravichandran KS
Adv Exp Med Biol; 2016; 930():25-49. PubMed ID: 27558816
[TBL] [Abstract][Full Text] [Related]
3. Efferocytosis Signaling in the Regulation of Macrophage Inflammatory Responses.
Elliott MR; Koster KM; Murphy PS
J Immunol; 2017 Feb; 198(4):1387-1394. PubMed ID: 28167649
[TBL] [Abstract][Full Text] [Related]
4. The many ways tissue phagocytes respond to dying cells.
Blander JM
Immunol Rev; 2017 May; 277(1):158-173. PubMed ID: 28462530
[TBL] [Abstract][Full Text] [Related]
5. Programmed cell clearance.
Fadeel B
Cell Mol Life Sci; 2003 Dec; 60(12):2575-85. PubMed ID: 14685684
[TBL] [Abstract][Full Text] [Related]
6. Understanding the diversity and dynamics of in vivo efferocytosis: Insights from the fly embryo.
Heron R; Amato C; Wood W; Davidson AJ
Immunol Rev; 2023 Oct; 319(1):27-44. PubMed ID: 37589239
[TBL] [Abstract][Full Text] [Related]
7. Immunogenicity of cancer cells: An overview.
Singh T; Bhattacharya M; Mavi AK; Gulati A; Rakesh ; Sharma NK; Gaur S; Kumar U
Cell Signal; 2024 Jan; 113():110952. PubMed ID: 38084844
[TBL] [Abstract][Full Text] [Related]
8. Phagocytic clearance of dying cells and its implications.
Ravichandran KS
Immunol Rev; 2023 Oct; 319(1):4-6. PubMed ID: 37858307
[No Abstract] [Full Text] [Related]
9. What's the deal with efferocytosis and asthma?
Martinez J; Cook DN
Trends Immunol; 2021 Oct; 42(10):904-919. PubMed ID: 34503911
[TBL] [Abstract][Full Text] [Related]
10. Phagocytosis Assay of Necroptotic Cells by Cardiac Myofibroblasts.
Horii Y; Matsuda S; Watari K; Nagasaka A; Kurose H; Nakaya M
Bio Protoc; 2017 Sep; 7(18):e2552. PubMed ID: 34541198
[TBL] [Abstract][Full Text] [Related]
11. Dying cell recognition shapes the pathophysiology of cell death.
Kroemer G
Cell Death Differ; 2016 Jun; 23(6):913-4. PubMed ID: 27157319
[No Abstract] [Full Text] [Related]
12. Kazuo Ishiguro's screenplay for "Living": A treatise on how to live when dying.
Abrams R; Ali K
J Am Geriatr Soc; 2023 Oct; ():. PubMed ID: 37840330
[No Abstract] [Full Text] [Related]
13. Harnessing DNA for immunotherapy: Cancer, infectious diseases, and beyond.
Wang Y; Chen-Mayfield TJ; Li Z; Younis MH; Cai W; Hu Q
Adv Funct Mater; 2022 Sep; 32(37):. PubMed ID: 36304724
[TBL] [Abstract][Full Text] [Related]
14. Oncolyic Virotherapy for Prostate Cancer: Lighting a Fire in Winter.
Wang G; Liu Y; Liu S; Lin Y; Hu C
Int J Mol Sci; 2022 Oct; 23(20):. PubMed ID: 36293504
[TBL] [Abstract][Full Text] [Related]
15. The immune response to secondary necrotic cells.
Sachet M; Liang YY; Oehler R
Apoptosis; 2017 Oct; 22(10):1189-1204. PubMed ID: 28861714
[TBL] [Abstract][Full Text] [Related]
16. Crosstalk between Stem and Progenitor Cellular Mediators with Special Emphasis on Vasculogenesis.
Rohban R; Prietl B; Pieber TR
Transfus Med Hemother; 2017 Jun; 44(3):174-182. PubMed ID: 28626368
[TBL] [Abstract][Full Text] [Related]
17. CD73 regulates anti-inflammatory signaling between apoptotic cells and endotoxin-conditioned tissue macrophages.
Murphy PS; Wang J; Bhagwat SP; Munger JC; Janssen WJ; Wright TW; Elliott MR
Cell Death Differ; 2017 Mar; 24(3):559-570. PubMed ID: 28060378
[TBL] [Abstract][Full Text] [Related]
18. Immunogenic versus tolerogenic phagocytosis during anticancer therapy: mechanisms and clinical translation.
Garg AD; Romano E; Rufo N; Agostinis P
Cell Death Differ; 2016 Jun; 23(6):938-51. PubMed ID: 26891691
[TBL] [Abstract][Full Text] [Related]
19. Anticancer and apoptotic effects on cell proliferation of diosgenin isolated from Costus speciosus (Koen.) Sm.
Selim S; Al Jaouni S
BMC Complement Altern Med; 2015 Sep; 15():301. PubMed ID: 26329920
[TBL] [Abstract][Full Text] [Related]
20. Consensus guidelines for the detection of immunogenic cell death.
Kepp O; Senovilla L; Vitale I; Vacchelli E; Adjemian S; Agostinis P; Apetoh L; Aranda F; Barnaba V; Bloy N; Bracci L; Breckpot K; Brough D; Buqué A; Castro MG; Cirone M; Colombo MI; Cremer I; Demaria S; Dini L; Eliopoulos AG; Faggioni A; Formenti SC; Fučíková J; Gabriele L; Gaipl US; Galon J; Garg A; Ghiringhelli F; Giese NA; Guo ZS; Hemminki A; Herrmann M; Hodge JW; Holdenrieder S; Honeychurch J; Hu HM; Huang X; Illidge TM; Kono K; Korbelik M; Krysko DV; Loi S; Lowenstein PR; Lugli E; Ma Y; Madeo F; Manfredi AA; Martins I; Mavilio D; Menger L; Merendino N; Michaud M; Mignot G; Mossman KL; Multhoff G; Oehler R; Palombo F; Panaretakis T; Pol J; Proietti E; Ricci JE; Riganti C; Rovere-Querini P; Rubartelli A; Sistigu A; Smyth MJ; Sonnemann J; Spisek R; Stagg J; Sukkurwala AQ; Tartour E; Thorburn A; Thorne SH; Vandenabeele P; Velotti F; Workenhe ST; Yang H; Zong WX; Zitvogel L; Kroemer G; Galluzzi L
Oncoimmunology; 2014 Oct; 3(9):e955691. PubMed ID: 25941621
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
